• 2234 Citations
  • 21 Scopus h-Index
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer

Kohli, M., Tan, W., Zheng, T., Wang, A., Montesinos, C., Wong, C., Du, P., Jia, S., Yadav, S., Horvath, L. G., Mahon, K. L., Kwan, E. M., Fettke, H., Yu, J. & Azad, A. A., Apr 2020, In : EBioMedicine. 54, 102728.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer

Fettke, H., Kwan, E. M., Docanto, M. M., Bukczynska, P., Ng, N., Graham, L. J. K., Mahon, K., Hauser, C., Tan, W., Wang, X. H., Zhao, Z., Zheng, T., Zhou, K., Du, P., Yu, J., Huang, Y., Jia, S., Kohli, M., Horvath, L. G. & Azad, A. A., Aug 2020, In : European urology. 78, 2, p. 173-180 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

Complete remission with immunotherapy: Case report of a patient with metastatic bladder cancer to the humerus

Abdelhakam, D., Young, P. R., Jain, M. K., Nassar, A., Copland, J. A. & Tan, W., May 2020, In : Urology Case Reports. 30, 101130.

Research output: Contribution to journalArticle

Open Access

Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer

Du, M., Tian, Y., Tan, W., Wang, L., Wang, L., Kilari, D., Huang, C. C., Wang, L. & Kohli, M., Jan 1 2020, (Accepted/In press) In : Prostate Cancer and Prostatic Diseases.

Research output: Contribution to journalArticle

1 Scopus citations

The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients

You, B., Mercier, F., Assenat, E., Langlois-Jacques, C., Glehen, O., Soulé, J., Payen, L., Kepenekian, V., Dupuy, M., Belouin, F., Morency, E., Saywell, V., Flacelière, M., Elies, P., Liaud, P., Mazard, T., Maucort-Boulch, D., Tan, W., Vire, B., Villeneuve, L. & 4 others, Ychou, M., Kohli, M., Joubert, D. & Prieur, A., Jan 2020, In : EBioMedicine. 51, 102574.

Research output: Contribution to journalArticle

Open Access
2019

Oncologists' Attitudes and Practice of Addressing Diet, Physical Activity, and Weight Management With Patients With Cancer: Findings of an ASCO Survey of the Oncology Workforce

Ligibel, J. A., Jones, L. W., Brewster, A. M., Clinton, S. K., Korde, L. A., Oeffinger, K. C., Bender, C. M., Tan, W., Merrill, J. K., Katta, S. & Alfano, C. M., Jun 1 2019, In : Journal of oncology practice. 15, 6, p. e520-e528

Research output: Contribution to journalArticle

6 Scopus citations

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

for the MASCC Bone Study Group, Feb 1 2019, In : Supportive Care in Cancer. 27, 2, p. 383-394 12 p.

Research output: Contribution to journalReview article

17 Scopus citations

Phase II trial of eribulin in patients with metastatic hormone refractory prostate cancer: A trial of the ECOG-ACRIN Cancer Research Group (E5805)

Stein, M. N., Chen, Y. H., Carducci, M. A., Hudes, G. R., Lerma, P. M., Tan, W. W., Dalune, R., Rowland, K. M., Kuzel, T. M. & DiPaola, R. S., Apr 1 2019, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 42, 4, p. 375-381 7 p.

Research output: Contribution to journalArticle

Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

Kumar, V., Ailawadhi, S., Bojanini, L., Mehta, A., Biswas, S., Sher, T., Roy, V., Vishnu, P., Marin-Acevedo, J., Alegria, V. R., Paulus, A., Aulakh, S., Iqbal, M., Manochakian, R., Tan, W., Chanan-Khan, A. & Ailawadhi, M., Oct 1 2019, In : Blood cancer journal. 9, 10, 75.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
2018

A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone

Wang, L., Dehm, S. M., Hillman, D. W., Sicotte, H., Tan, W., Gormley, M., Bhargava, V., Jimenez, R., Xie, F., Yin, P., Qin, S., Quevedo, F., Costello, B. A., Pitot, H. C., Ho, T., Bryce, A. H., Ye, Z., Li, Y., Eiken, P., Vedell, P. T. & 16 others, Barman, P., McMenomy, B. P., Atwell, T. D., Carlson, R. E., Ellingson, M., Eckloff, B. W., Qin, R., Ou, F., Hart, S. N., Huang, H., Jen, J., Wieben, E. D., Kalari, K. R., Weinshilboum, R. M., Wang, L. & Kohli, M., Feb 1 2018, In : Annals of Oncology. 29, 2, p. 352-360 9 p.

Research output: Contribution to journalArticle

21 Scopus citations

Best Practices for Physician-Scientist Training Programs: Recommendations from the Alliance for Academic Internal Medicine

Blanchard, M., Burton, M. C., Geraci, M. W., Madaio, M. P., Marsh, J. D., Proweller, A., Rockey, D. C., Salata, R. A., Tan, W., Williams, C. S., Zaidi, M. & Todd, R. F., May 1 2018, In : American Journal of Medicine. 131, 5, p. 578-584 7 p.

Research output: Contribution to journalComment/debate

5 Scopus citations

Breast cancer metastasis to the bladder: A literature review

Kase, A. M., Menke, D. & Tan, W., 2018, In : BMJ case reports. 2018, bcr-2017-222031.

Research output: Contribution to journalArticle

4 Scopus citations

Corrigendum: N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: A North Central Cancer Treatment Group (NCCTG) Trial (Ann Oncol (2010) 21 (493–497) DOI: 10.1093/annonc/mdp328)

Tan, W. W., Hillman, D. W., Salim, M., Northfelt, D. W., Anderson, D. M., Stella, P. J., Niedringhaus, R., Bernath, A. M., Gamini, S. S., Palmieri, F. & Perez, E. A., Jan 1 2018, In : Annals of Oncology. 29, 10, p. 493-497 5 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer

Norton, N., Fox, N., McCarl, C. A., Tenner, K. S., Ballman, K. V., Erskine, C. L., Necela, B. M., Northfelt, D., Tan, W. W., Calfa, C., Pegram, M., Colon-Otero, G., Perez, E. A., Clynes, R. & Knutson, K. L., Jun 14 2018, In : Breast Cancer Research. 20, 1, 52.

Research output: Contribution to journalArticle

5 Scopus citations

High p95HER2/HER2 ratio associated with poor outcome in trastuzumab-treated HER2-positive metastatic breast cancer ncctg N0337 and NCCTG 98-32-52 (Alliance)

Chumsri, S., Sperinde, J., Liu, H., Gligorov, J., Spano, J. P., Antoine, M., Aspitia, A. M., Tan, W., Winslow, J., Petropoulos, C. J., Chenna, A., Bates, M., Weidler, J. M., Huang, W., Dueck, A. & Perez, E. A., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3053-3058 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma

Niazi, S. K., Frank, R. D., Sharma, M., Roy, V., Ames, S. C., Rummans, T. A., Spaulding, A., Sher, T., Ailawadhi, M., Bhatia, K., Ahmed, S., Tan, W., Chanan-Khan, A. & Ailawadhi, S., May 22 2018, In : Blood Advances. 2, 10, p. 1120-1128 9 p.

Research output: Contribution to journalArticle

1 Scopus citations

Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

Kohli, M., Li, J., Du, M., Hillman, D. W., Dehm, S. M., Tan, W., Carlson, R., Campion, M. B., Wang, L., Wang, L. M., Zhang, H., Zhang, P., Kilari, D., Huang, C. C. & Wang, L., Jun 1 2018, (Accepted/In press) In : Prostate Cancer and Prostatic Diseases. p. 1-8 8 p.

Research output: Contribution to journalArticle

8 Scopus citations

Rare paraneoplastic dermatomyositis secondary to high-grade bladder cancer

Kase, A. M., Swaika, A., Geiger, X. J. & Tan, W., Mar 1 2018, In : Journal of Community and Supportive Oncology. 16, 2, p. e97-e99

Research output: Contribution to journalArticle

Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer

Giridhar, K. V., Sanhueza, C., Hillman, D. W., Alkhateeb, H., Carlson, R., Tan, W., Costello, B. A., Quevedo, F., Pagliaro, L. & Kohli, M., Sep 1 2018, In : Prostate Cancer and Prostatic Diseases. 21, 3, p. 431-437 7 p.

Research output: Contribution to journalArticle

5 Scopus citations

UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer

Campone, M., Lacroix-Triki, M., Roca, L., Spielmann, M., Wildiers, H., Cottu, P., Kerbrat, P., Levy, C., Desmoulins, I., Bachelot, T., Tan, W., Eymard, J. C., Uwer, L., Duhoux, F. P., Verhoeven, D., Jaubert, D., Coeffic, D., Orfeuvre, H., Canon, J. L., Asselain, B. & 3 others, Martin, A. L., Lemonnier, J. & Roché, H., Nov 1 2018, In : European Journal of Cancer. 103, p. 184-194 11 p.

Research output: Contribution to journalArticle

2017

Androgen receptor variant AR-V9 is coexpressed with AR-V7 in prostate cancer metastases and predicts abiraterone resistance

Kohli, M., Ho, Y., Hillman, D. W., Van Etten, J. L., Henzler, C., Yang, R., Sperger, J. M., Li, Y., Tseng, E., Hon, T., Clark, T., Tan, W., Carlson, R. E., Wang, L., Sicotte, H., Thai, H., Jimenez, R., Huang, H., Vedell, P. T., Eckloff, B. W. & 9 others, Quevedo, J. F., Pitot, H. C., Costello, B. A., Jen, J., Wieben, E. D., Silverstein, K. A. T., Lang, J. M., Wang, L. & Dehm, S. M., Aug 15 2017, In : Clinical Cancer Research. 23, 16, p. 4704-4715 12 p.

Research output: Contribution to journalArticle

52 Scopus citations

Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes

Ho, T. H., Serie, D. J., Parasramka, M., Cheville, J. C., Bot, B. M., Tan, W., Wang, L. M., Joseph, R. W., Hilton, T., Leibovich, B. C., Parker, A. & Eckel-Passow, J. E., 2017, In : Annals of Oncology. 28, 3, p. 604-610 7 p.

Research output: Contribution to journalArticle

26 Scopus citations

Personalized chemotherapy selection for breast cancer using gene expression profiles

Yu, K., Sang, Q. X. A., Lung, P. Y., Tan, W., Lively, T., Sheffield, C., Bou-Dargham, M. J., Liu, J. S. & Zhang, J., Mar 3 2017, In : Scientific Reports. 7, 43294.

Research output: Contribution to journalArticle

5 Scopus citations
2016

Active surveillance for the management of localized prostate cancer (Cancer Care Ontario guideline): American society of clinical oncology clinical practice guideline endorsement

Chen, R. C., Bryan Rumble, R., Andrew Loblaw, D., Finelli, A., Ehdaie, B., Cooperberg, M. R., Morgan, S. C., Tyldesley, S., Haluschak, J. J., Tan, W., Justman, S. & Jain, S., Jun 20 2016, In : Journal of Clinical Oncology. 34, 18, p. 2182-2190 9 p.

Research output: Contribution to journalArticle

156 Scopus citations

Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer

Hart, S. N., Ellingson, M. S., Schahl, K., Vedell, P. T., Carlson, R. E., Sinnwell, J. P., Barman, P., Sicotte, H., Eckel-Passow, J. E., Wang, L., Kalari, K. R., Qin, R., Kruisselbrink, T. M., Jimenez, R. E., Bryce, A. H., Tan, W., Weinshilboum, R., Wang, L. & Kohli, M., 2016, In : BMJ open. 6, 4, e010332.

Research output: Contribution to journalArticle

16 Scopus citations

Improved survival of HER2+ breast cancer patients treated with trastuzumab and chemotherapy is associated with host antibody immunity against the HER2 intracellular domain

Knutson, K. L., Clynes, R., Shreeder, B., Yeramian, P., Kemp, K. P., Ballman, K. V., Tenner, K. S., Erskine, C. L., Norton, N., Northfelt, D., Tan, W., Calfa, C., Pegram, M., Mittendorf, E. A. & Perez, E. A., Jul 1 2016, In : Cancer Research. 76, 13, p. 3702-3710 9 p.

Research output: Contribution to journalArticle

29 Scopus citations

Phase i Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

Tan, W., Allred, J. B., Moreno Aspitia, A., Northfelt, D. W., Ingle, J. N., Goetz, M. P. & Perez, E. A., Apr 1 2016, In : Clinical Breast Cancer. 16, 2, p. 82-86 5 p.

Research output: Contribution to journalArticle

17 Scopus citations

Safety and efficacy of durvalumab (MEDI4736), an anti-programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer

Massard, C., Gordon, M. S., Sharma, S., Rafii, S., Wainberg, Z. A., Luke, J., Curiel, T. J., Colon-Otero, G., Hamid, O., Sanborn, R. E., O'Donnell, P. H., Drakaki, A., Tan, W., Kurland, J. F., Rebelatto, M. C., Jin, X., Blake-Haskins, J. A., Gupta, A. & Segal, N. H., Sep 10 2016, In : Journal of Clinical Oncology. 34, 26, p. 3119-3125 7 p.

Research output: Contribution to journalArticle

438 Scopus citations
2015

Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer

Huang, X., Yuan, T., Liang, M., Du, M., Xia, S., Dittmar, R., Wang, D., See, W., Costello, B. A., Quevedo, F., Tan, W., Nandy, D., Bevan, G. H., Longenbach, S., Sun, Z., Lu, Y., Wang, T., Thibodeau, S. N., Boardman, L., Kohli, M. & 1 others, Wang, L., Jan 1 2015, In : European urology. 67, 1, p. 33-41 9 p.

Research output: Contribution to journalArticle

256 Scopus citations

Kidney and Ureteral Carcinoma

Wong, W. W., Peterson, J. L., Tan, W., Haddock, M., Parker, A., Wehle, M. J. & Hutchinson, R. C., Jan 1 2015, Clinical Radiation Oncology. Elsevier Inc., p. 1139-1159.e5

Research output: Chapter in Book/Report/Conference proceedingChapter

The Estrogen Pathway: Estrogen Receptor-α, Progesterone Receptor, and Estrogen Receptor-β Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens

Tan, W., Boorjian, S., Advani, P., Farmer, S., Lohse, C., Cheville, J., Kwon, E. D. & Leibovich, B., Oct 1 2015, In : Clinical Genitourinary Cancer. 13, 5, p. 476-484 9 p.

Research output: Contribution to journalArticle

14 Scopus citations
2014

Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC)

Gupta, E., Guthrie, T. & Tan, W., Jul 25 2014, In : BMC Urology. 14, 1, 55.

Research output: Contribution to journalReview article

20 Scopus citations

Editorial comment

Tan, W. W., Jan 1 2014, In : Urology. 83, 1, 1 p.

Research output: Contribution to journalComment/debate

Integrated smoking cessation and binge drinking intervention for young adults: A pilot efficacy trial

Ames, S. C., Pokorny, S. B., Schroeder, D. R., Tan, W. & Werch, C. E., May 2014, In : Addictive Behaviors. 39, 5, p. 848-853 6 p.

Research output: Contribution to journalArticle

13 Scopus citations
2013

A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer

Pili, R., Qin, R., Flynn, P. J., Picus, J., Millward, M., Ho, W. M., Pitot, H., Tan, W., Miles, K. M., Erlichman, C. & Vaishampayan, U., Dec 1 2013, In : Clinical Genitourinary Cancer. 11, 4, p. 477-483 7 p.

Research output: Contribution to journalArticle

49 Scopus citations

Ataxia in a patient with urothelial carcinoma: Pathologic confirmation, recovery, and improved survival

Gardner, F. P. & Tan, W. W., Jul 1 2013, In : Clinical Advances in Hematology and Oncology. 11, 7, p. 465-467 3 p.

Research output: Contribution to journalArticle

2 Scopus citations

Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrence

Tan, W. W., Heckman, M. G., Vishnu, P., Crook, J. E., Younkin, L. H., Covil, E. G., Ferman, T. J., Graff-Radford, N. R., Younkin, S. G., Smallridge, R. C., Wehle, M. J. & Buskirk, S. J., Jan 1 2013, In : Urology. 81, 1, p. 150-154 5 p.

Research output: Contribution to journalArticle

3 Scopus citations
8 Scopus citations

Reply

Tan, W., Jan 1 2013, In : Urology. 81, 1, 1 p.

Research output: Contribution to journalComment/debate

Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma

Von Roemeling, C. A., Marlow, L. A., Wei, J. J., Cooper, S. J., Caulfield, T. R., Wu, K., Tan, W. W., Tun, H. W. & Copland, J. A., May 1 2013, In : Clinical Cancer Research. 19, 9, p. 2368-2380 13 p.

Research output: Contribution to journalArticle

102 Scopus citations
2012

Papules of unknown aetiology

Andhavarapu, S. & Tan, W. W., Sep 7 2012, In : New Zealand Medical Journal. 125, 1361, p. 102-104 3 p.

Research output: Contribution to journalArticle

Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: A north central cancer treatment group trial

Tan, W. W., Allred, J. B., Salim, M., Flynn, P., Fishkin, P. A. S., Stella, P. J., Wiesenfeld, M., Bernath, A. M., Fitch, T. R. & Perez, E. A., Apr 2012, In : Clinical breast cancer. 12, 2, p. 81-86 6 p.

Research output: Contribution to journalArticle

7 Scopus citations
2011

A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer

Ames, S. C., Tan, W. W., Ames, G. E., Stone, R. L., Rizzo, T. D., Crook, J. E., Williams, C. R., Werch, C. E., Clark, M. M. & Rummans, T. A., Apr 1 2011, In : Psycho-Oncology. 20, 4, p. 435-440 6 p.

Research output: Contribution to journalArticle

14 Scopus citations

Current therapeutic strategies for invasive and metastatic bladder cancer

Vishnu, P., Mathew, J. & Tan, W. W., 2011, In : OncoTargets and Therapy. 4, p. 97-113 17 p.

Research output: Contribution to journalReview article

31 Scopus citations

Kidney and Ureteral Carcinoma

Wong, W. W., Buskirk, S. J., Tan, W., Peterson, J. L., Haddock, M., Parker, A. & Wehle, M. J., Oct 27 2011, Clinical Radiation Oncology: Third Edition. Elsevier Inc., p. 1145-1165 21 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Quality of life of patients undergoing surgical treatment for newly-diagnosed, clinically localized renal cell carcinoma

Ames, S. C., Parker, A. S., Crook, J. E., Diehl, N. N., Tan, W. W., Williams, C. R. & Ames, G. E., Oct 1 2011, In : Journal of Psychosocial Oncology. 29, 6, p. 593-605 13 p.

Research output: Contribution to journalArticle

6 Scopus citations

Treatment of men with rising prostate-specific antigen levels following radical prostatectomy

Tzou, K., Tan, W. W. & Buskirk, S., Jan 1 2011, In : Expert review of anticancer therapy. 11, 1, p. 125-136 12 p.

Research output: Contribution to journalReview article

7 Scopus citations
2010

Editorial Comment

Tan, W. W., May 1 2010, In : Urology. 75, 5, 1 p.

Research output: Contribution to journalComment/debate

Prognosis and outcome of small (≤1 cm), node-negative breast cancer on the basis of hormonal and her-2 status

Amar, S., Mccullough, A. E., Tan, W., Geiger, X. J., Boughey, J. C., McNeil, R. B., Coppola, K. E., Mclaughlin, S. A., Palmieri, F. M. & Perez, E. A., Oct 2010, In : Oncologist. 15, 10, p. 1043-1049 7 p.

Research output: Contribution to journalArticle

30 Scopus citations

Update on options for treatment of metastatic castration-resistant prostate cancer

Vishnu, P. & Tan, W. W., Apr 28 2010, In : OncoTargets and Therapy. 3, p. 39-51 13 p.

Research output: Contribution to journalReview article

31 Scopus citations